Klinikverbund Suedwest GmbH
- Address
- Arthur-Gruber-Str. 70, 71065 Sindelfingen, Germany
Klinikverbund Suedwest GmbH - Hematologic Malignancy Research
Klinikverbund Suedwest GmbH is a clinical research center dedicated to advancing treatment options for patients with hematologic malignancies. The center specializes in investigating novel therapeutic combinations for patients who are not candidates for conventional treatment approaches, with particular emphasis on acute myeloid leukemia (AML) management in vulnerable patient populations.
- Novel combination therapies using Venetoclax and Azacitidine in acute myeloid leukemia
- Treatment strategies for elderly or medically unfit patients ineligible for standard induction therapy
- Pilot studies evaluating innovative dosing schedules in hematologic cancers
The center demonstrates expertise in conducting early-phase clinical trials that explore alternative treatment regimens for treatment-naïve AML patients aged 18 years and older. By focusing on patients who cannot tolerate intensive chemotherapy, Klinikverbund Suedwest GmbH addresses critical unmet medical needs in hematology-oncology and contributes valuable data on targeted therapy combinations that may offer more tolerable yet effective treatment options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikverbund Suedwest GmbH
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Adjuvant Dynamic Marker-Adjusted Personalized Therapy: Ribociclib Plus Endocrine Therapy Versus Chemotherapy in HR+/HER2- Early Breast Cancer | WSG Westdeutsche Studiengruppe GmbH | Phase III | Not Recruiting | Jul 2019 | — |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azacitidine | 1 | Unknown | 2023-05-16 | 2023-05-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.